TRIM49D1

gene
On this page

Also known as TRIM49D

Summary

TRIM49D1 (tripartite motif containing 49D1, HGNC:43973) is a protein-coding gene on chromosome 11q14.3, encoding Tripartite motif-containing protein 49D (C9J1S8).

Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response and regulation of gene expression. Predicted to be active in cytoplasm.

Source: NCBI Gene 399939 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 24 total
  • MANE Select transcript: NM_001384911

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:43973
Approved symbolTRIM49D1
Nametripartite motif containing 49D1
Location11q14.3
Locus typegene with protein product
StatusApproved
AliasesTRIM49D
Ensembl geneENSG00000223417
Ensembl biotypeprotein_coding
Entrez399939

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 protein_coding

ENST00000420869, ENST00000530311, ENST00000605881

RefSeq mRNA: 2 — MANE Select: NM_001384911 NM_001206627, NM_001384911

CCDS: CCDS60930

Canonical transcript exons

ENST00000420869 — 8 exons

ExonStartEnd
ENSE000016536038991140989912086
ENSE000017454708992029989920509
ENSE000035066828991691989917014
ENSE000035693308991491289915142
ENSE000036150888991730089917714
ENSE000036158508991320489913301
ENSE000036656308991417589914197
ENSE000039167108992185289922245

Expression profiles

Bgee: expression breadth broad, 14 present calls, max score 87.09.

Top tissues by expression

128 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047387.09gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099182.94gold quality
monocyteCL:000057643.44gold quality
leukocyteCL:000073842.02gold quality
ganglionic eminenceUBERON:000402337.25gold quality
colonic epitheliumUBERON:000039737.20gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
bone marrow cellCL:000209236.16gold quality
bone marrowUBERON:000237134.66silver quality
skeletal muscle tissueUBERON:000113433.38gold quality
duodenumUBERON:000211432.87silver quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
muscle tissueUBERON:000238532.13gold quality
bloodUBERON:000017831.97silver quality
prefrontal cortexUBERON:000045131.40gold quality
sural nerveUBERON:001548830.93gold quality
primary visual cortexUBERON:000243630.76gold quality
stromal cell of endometriumCL:000225529.87gold quality
frontal cortexUBERON:000187029.22silver quality
liverUBERON:000210729.06gold quality
dorsolateral prefrontal cortexUBERON:000983427.97silver quality
lymph nodeUBERON:000002927.57gold quality
cerebral cortexUBERON:000095627.19silver quality
tonsilUBERON:000237227.05gold quality
urinary bladderUBERON:000125526.88gold quality
superior frontal gyrusUBERON:000266126.88gold quality
islet of LangerhansUBERON:000000626.55gold quality
vermiform appendixUBERON:000115426.42gold quality
gall bladderUBERON:000211025.98gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes2.63
E-MTAB-6386no29.81

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

12 targeting TRIM49D1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-188-3P100.0068.761240
HSA-MIR-124-3P99.8973.743043
HSA-MIR-506-3P99.8973.553057
HSA-MIR-5582-5P99.2771.421879
HSA-MIR-520E-5P99.2768.901513
HSA-MIR-472199.2666.05818
HSA-MIR-6506-5P99.0465.661386
HSA-MIR-619-5P98.5764.971988
HSA-MIR-676-3P97.8665.70668
HSA-MIR-10526-3P97.8664.971342
HSA-MIR-431497.5067.301369
HSA-MIR-2355-3P96.8468.54909

Cross-species orthologs

0 orthologs

Paralogs (80): MID2 (ENSG00000080561), TRIM9 (ENSG00000100505), MID1 (ENSG00000101871), MEFV (ENSG00000103313), TRIM35 (ENSG00000104228), TRIM14 (ENSG00000106785), TRIM37 (ENSG00000108395), TRIM2 (ENSG00000109654), TRIM3 (ENSG00000110171), TRIM38 (ENSG00000112343), TRIM62 (ENSG00000116525), TRIM67 (ENSG00000119283), TRIM32 (ENSG00000119401), BSPRY (ENSG00000119411), TRIM25 (ENSG00000121060), TRIM6 (ENSG00000121236), TRIM24 (ENSG00000122779), TRIM51 (ENSG00000124900), TRIM28 (ENSG00000130726), TRIM21 (ENSG00000132109), TRIM5 (ENSG00000132256), TRIM22 (ENSG00000132274), TRIM47 (ENSG00000132481), TRIM45 (ENSG00000134253), TRIM29 (ENSG00000137699), TRIM54 (ENSG00000138100), PML (ENSG00000140464), TRIM65 (ENSG00000141569), TRIM43B (ENSG00000144010), TRIM43 (ENSG00000144015), TRIM7 (ENSG00000146054), TRIM41 (ENSG00000146063), TRIM50 (ENSG00000146755), TRIM4 (ENSG00000146833), TRIM55 (ENSG00000147573), TRIM48 (ENSG00000150244), TRIM36 (ENSG00000152503), TRIM11 (ENSG00000154370), TRIM74 (ENSG00000155428), TRIM42 (ENSG00000155890)

Protein

Protein identifiers

Tripartite motif-containing protein 49DC9J1S8 (reviewed: C9J1S8)

Alternative names: Tripartite motif-containing protein 49-like protein, Tripartite motif-containing protein 49D1, Tripartite motif-containing protein 49D2

All UniProt accessions (2): A0A087WVN7, C9J1S8

UniProt curated annotations — full annotation on UniProt →

Similarity. Belongs to the TRIM/RBCC family.

RefSeq proteins (2): NP_001193556, NP_001371840* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000315Znf_B-boxDomain
IPR001841Znf_RINGDomain
IPR001870B30.2/SPRYDomain
IPR003877SPRY_domDomain
IPR003879Butyrophylin_SPRYDomain
IPR013083Znf_RING/FYVE/PHDHomologous_superfamily
IPR013320ConA-like_dom_sfHomologous_superfamily
IPR043136B30.2/SPRY_sfHomologous_superfamily
IPR050143TRIM/RBCCFamily

Pfam: PF00622, PF00643, PF15227

UniProt features (10 total): binding site 4, zinc finger region 2, sequence conflict 2, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-C9J1S8-F185.990.65

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (4): 93; 96; 115; 121

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 12 (showing top): GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY, MIR506_3P, MIR124_3P, MIR619_5P, MIR4314, MIR2355_3P, MIR6506_5P, chr11q14, GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS

GO Biological Process (2): regulation of gene expression (GO:0010468), innate immune response (GO:0045087)

GO Molecular Function (4): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
gene expression1
regulation of macromolecule biosynthetic process1
immune response1
defense response to symbiont1
transition metal ion binding1
ubiquitin-protein transferase activity1
ubiquitin-like protein ligase activity1
binding1
cation binding1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

176 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TRIM49D1TEX101Q9BY14367
TRIM49D1CLEC2DQ9UHP7278
TRIM49D1SLC45A3Q96JT2272
TRIM49D1HMGXB4Q9UGU5249
TRIM49D1YWHAEP29360225
TRIM49D1STMN2Q93045224
TRIM49D1COMMD6Q7Z4G1203
TRIM49D1MS4A2Q01362202
TRIM49D1FOLH1Q04609200
TRIM49D1CAV2P51636199
TRIM49D1PPP1R14CQ8TAE6195
TRIM49D1MS4A1P08984190
TRIM49D1NAALAD2Q9Y3Q0184
TRIM49D1MAB21L2Q9Y586183
TRIM49D1TNFRSF12AQ9NP84180

IntAct

0 interactions, top by confidence:

BioGRID (1): TRIM49D2P (Negative Genetic)

ESM2 similar proteins: A0A3B3IT33, A6NCK2, A6NDI0, A6NGJ6, A6NI03, A6NLI5, C9J1S8, I1YAP6, K7N6K2, P0CI25, P0CI26, P15533, Q0PF16, Q1ACD5, Q1ACD6, Q1ACD7, Q1ACD8, Q2YEM8, Q2YEM9, Q2YEN0, Q2YEN2, Q3ZEE5, Q587N6, Q587N7, Q5BN31, Q5C8T6, Q5C8T8, Q5C8U1, Q5C8U3, Q5C8U4, Q5D7H7, Q5D7H8, Q5D7I0, Q5D7I1, Q5D7I2, Q5D7I3, Q5D7I5, Q5D7I6, Q5D7I9, Q5D7J0

Diamond homologs: A0A3B3IT33, A6NCK2, A6NDI0, A6NGJ6, A6NI03, A6NLI5, B0BLU1, C9J1S8, I1YAP6, O00478, O00481, O15344, O75677, O75678, O75679, O76064, P0CI25, P0CI26, P18892, P19474, P62603, P86448, P86449, Q13410, Q2HJ46, Q3C1V9, Q3TL54, Q4KLN8, Q5EBN2, Q5PQN2, Q5R4I2, Q5R996, Q61510, Q62556, Q6INS5, Q6MFY8, Q6UX41, Q6UXE8, Q6ZWI9, Q7T308

SIGNOR signaling

2 interactions.

AEffectBMechanism
Ub:E2“up-regulates activity”TRIM49D1ubiquitination

Disease & clinical

Clinical variants and AI predictions

ClinVar

24 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance19
Likely benign4
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

761 predictions. Top by Δscore:

VariantEffectΔscore
11:89912082:ATCCA:Aacceptor_gain1.0000
11:89912083:TCCA:Tacceptor_gain1.0000
11:89912084:CCA:Cacceptor_gain1.0000
11:89912084:CCAC:Cacceptor_gain1.0000
11:89912085:CA:Cacceptor_gain1.0000
11:89912085:CAC:Cacceptor_gain1.0000
11:89912085:CACTG:Cacceptor_loss1.0000
11:89912086:ACTGC:Aacceptor_loss1.0000
11:89912087:C:CCacceptor_gain1.0000
11:89912087:CT:Cacceptor_loss1.0000
11:89913199:CTTA:Cdonor_loss1.0000
11:89913200:TTA:Tdonor_loss1.0000
11:89913201:TACC:Tdonor_loss1.0000
11:89913202:A:ACdonor_gain1.0000
11:89913202:A:Tdonor_loss1.0000
11:89913202:AC:Adonor_gain1.0000
11:89913203:C:CAdonor_loss1.0000
11:89913203:C:CCdonor_gain1.0000
11:89913203:CC:Cdonor_gain1.0000
11:89913203:CCT:Cdonor_gain1.0000
11:89913297:CACTC:Cacceptor_gain1.0000
11:89913299:CTC:Cacceptor_gain1.0000
11:89913300:TC:Tacceptor_gain1.0000
11:89913301:CC:Cacceptor_gain1.0000
11:89913301:CCTGC:Cacceptor_loss1.0000
11:89913302:C:CCacceptor_gain1.0000
11:89913302:CTGC:Cacceptor_loss1.0000
11:89913303:T:Cacceptor_loss1.0000
11:89915143:CT:Cacceptor_loss1.0000
11:89917295:CTTA:Cdonor_loss1.0000

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1001164854 (11:89920771 G>C), RS1001912426 (11:89920855 C>A,T), RS1002914345 (11:89921865 C>T), RS1002940177 (11:89923395 T>C), RS1003025300 (11:89922019 C>G), RS1003319530 (11:89923215 T>G), RS1004617406 (11:89911846 T>C), RS1004741188 (11:89923650 G>A,C,T), RS1006309967 (11:89922361 A>C), RS1007112224 (11:89921793 T>C), RS1007557561 (11:89921578 T>C), RS1008151356 (11:89922671 C>G,T), RS1008532381 (11:89922994 G>A), RS1008534714 (11:89922896 T>C), RS1008598266 (11:89923922 A>G,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST90002380_103Basophil percentage of white cells2.000000e-10

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0007992basophil percentage of leukocytes

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

2 total (human), top 2 by PubMed support.

ChemicalActions (top 5)PubMed papers
Resveratrolaffects cotreatment, decreases expression1
Copperaffects cotreatment, decreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.